Healthy people needed to test safety of experimental drug
NCT ID NCT07046559
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 30 times
Summary
This study is an early test of a new drug called LY4066708 in 104 healthy adults. The main goal is to check for side effects and see how the drug moves through the body and brain. Participants will be followed for up to 24 weeks. This study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit
RECRUITINGHolbeck, Leeds, LS11 9EH, United Kingdom
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.